Supplementary Materialsblood793760-suppl1. to judge pre- and posttreatment risk elements for an infection, respectively. The cohort included sufferers with severe lymphoblastic leukemia (ALL; n = 47), chronic lymphocytic leukemia (n = 24), and non-Hodgkin lymphoma (n = 62). There have been 43 attacks in 30 of 133 sufferers (23%) within 28 times after CARCT-cell infusion with… Continue reading Supplementary Materialsblood793760-suppl1. to judge pre- and posttreatment risk elements for an